Saluda Medical Pty Ltd. Sustainability Profile
Saluda Medical Pty Ltd, headquartered in Australia, is a pioneering company in the medical technology industry, specialising in innovative neuromodulation solutions. Founded in 2015, Saluda has rapidly established itself as a leader in the development of advanced spinal cord stimulation systems, particularly known for its unique closed-loop technology that optimises pain management for patients with chronic pain conditions. With a strong operational presence across Australia and expanding into international markets, Saluda Medical is committed to enhancing patient outcomes through its cutting-edge products. The company’s flagship product, the Evoke® spinal cord stimulation system, stands out for its ability to adapt stimulation in real-time, setting a new standard in the field. Saluda's dedication to research and development has positioned it as a notable player in the neuromodulation market, earning recognition for its innovative approach and commitment to improving quality of life for patients worldwide.
DitchCarbon Score
How does Saluda Medical Pty Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Saluda Medical Pty Ltd.'s score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Saluda Medical Pty Ltd.'s reported carbon emissions
Saluda Medical Pty Ltd., headquartered in Australia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Saluda Medical may not yet have established a comprehensive framework for addressing its carbon footprint or climate impact. In the context of the medical technology industry, many companies are increasingly focusing on sustainability and climate commitments. However, without specific initiatives or targets, Saluda Medical's position in this regard remains unclear. As the industry evolves, it may be beneficial for the company to consider developing measurable climate strategies to align with broader environmental goals.
How Carbon Intensive is Saluda Medical Pty Ltd.'s Industry?
How Carbon Intensive is Saluda Medical Pty Ltd.'s Location?
Saluda Medical Pty Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Saluda Medical Pty Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
